Y52.3
Coronary vasodilators, not elsewhere classified
⇄ Primary-code rule changed vs QĐ4469
Coding rules (TT06)
- ●Cannot be used as primary diagnosis
Coding guidance (WHO 2019)
Dipyridamole Excl.: beta-adrenoreceptor antagonists (Y51.7) calcium-channel blockers (Y52.1)
Sibling codes
Y52Agents primarily affecting the cardiovascular systemY52.0Cardiac-stimulant glycosides and drugs of similar actionY52.1Calcium-channel blockersY52.2Other antidysrhythmic drugs, not elsewhere classifiedY52.4Angiotensin-converting-enzyme inhibitorsY52.5Other antihypertensive drugs, not elsewhere classifiedY52.6Antihyperlipidaemic and antiarteriosclerotic drugsY52.7Peripheral vasodilatorsY52.8Antivaricose drugs, including sclerosing agentsY52.9Other and unspecified agents primarily affecting the cardiovascular system